BridgeMD
New treatment option for Myocardial Infarction
Official title Lymphatic Organs and Myocardium After Myocardial Infarction
ClinicalTrials.gov ID: NCT05519735
What this study is testing
- What it's testing
- The adaptive immune response plays an important role in myocardial healing and remodeling after acute myocardial infarction in patients. Therefore, the involved lymphocytes represent a novel target for therapeutic interventions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- patients with acute myocardial infarction (STEMI) who were treated with immediate catheterization
- stable clinical course
- male/female, above 18 years old
You likely can't join if
- hemodynamic instablity \> 48 h after immediate catherization
- known CAD
- known structural heart disease
- multi vessel disease
- NSTEMI
- sarcoidosis
See the full eligibility criteria
- patients with acute myocardial infarction (STEMI) who were treated with immediate catheterization
- stable clinical course
- male/female, above 18 years old
- hemodynamic instablity \> 48 h after immediate catherization
- known CAD
- known structural heart disease
- multi vessel disease
- NSTEMI
- sarcoidosis
- immunosuppressive therapy
- acute inflammatory disease
- no consent obtainable
- contraindiations for CMR
- impaired renal function
- active cardiac implants, ferromagnetic implants
- pregnancy, breast-feeding
The study team makes the final eligibility decision.
Where it's taking place
- Würzburg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Würzburg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.